The study involves one dose of LY3039478 given by mouth followed by an intravenous infusion
(IV) (via a tube linked to a small needle in the vein) of LY3039478. The results of this
study will help to answer the following research questions:
- How much LY3039478 gets into the blood stream when given by mouth as a capsule compared
to when given by an IV
- How long it takes the body to remove the study drug
- The safety of LY3039478 and any side effects that might be associated with it
Participation in the study is expected to last up to 7 weeks. There will be screening, a
single study period, and a follow-up.